本页面由Tiger Trade Technology Pte. Ltd.提供服务

Mineralys Therapeutics, Inc.

28.93
+1.053.77%
盘前28.67-0.2600-0.90%04:21 EST
成交量:102.92万
成交额:2,979.30万
市值:22.90亿
市盈率:-10.10
高:29.53
开:27.83
低:27.83
收:27.88
52周最高:47.65
52周最低:8.24
股本:7,914.00万
流通股本:5,573.32万
量比:1.03
换手率:1.85%
股息:- -
股息率:- -
每股收益(TTM):-2.8636
每股收益(LYR):-3.6632
净资产收益率:-42.14%
总资产收益率:-26.50%
市净率:3.97
市盈率(LYR):-7.90

数据加载中...

2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

重要事件披露

Form 8-K - Current report
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]